Effect of Certolizumab Pegol On Signs and Symptoms in Patients with Psoriatic Arthritis with and without Prior Anti-TNF Exposure: 24 Week Results of a Phase 3 Double-Blind Randomized Placebo-Controlled Study
Author(s):
Mease, P.; Fleischmann, R.M.; Wollenhaupt, J.; Deodhar, A.A.; Kielar, D.; Woltering, F.; Stach, C.; Hoepken, B.; Arledge, T.; Heijde, D. van der
Published
2012
Publication type
Article / Letter to editor
Date issued
2012-10-31
Language
English
Is part of
Arthritis and Rheumatism (2012), Vol. 64, no. 10, p. S1107-S1107
